Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Treatment for H. pylori Eradication
NCT00132171Phase 3Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rabeprazole, amoxicillin, clarithromycin and tinidazole in Helicobacter pylori infection (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Helicobacter pylori eradication rate. Started Jan 2001; status: completed.
02
Drugs
rabeprazoleamoxicillinclarithromycintinidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT00132171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132171.